A synthetic opioid that has grown in popularity within the state’s illicit drug supply since 2019 is temporarily being ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

Swedish Orphan Biovitrum AB (BIOVF) reports a 22% revenue increase and significant strategic milestones, despite facing competitive pressures and restructuring challenges.

The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...

GSK Plc’s blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

Boston Scientific secured FDA approval to expand its FARAPULSE Pulsed Field Ablation system for persistent atrial ...

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific ...

US FDA accepts for review Milestone Pharma’s response to CRL for Cardamyst nasal spray: Montreal Monday, July 14, 2025, 11:00 Hrs [IST] Milestone Pharmaceuticals Inc., a biophar ...